Cargando…
Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580344/ https://www.ncbi.nlm.nih.gov/pubmed/34738920 http://dx.doi.org/10.18632/aging.203667 |
_version_ | 1784596594413273088 |
---|---|
author | Andrés‐Benito, Pol Domínguez, Raúl Colomina, Maria J. Llorens, Franc Povedano, Mònica Ferrer, Isidre |
author_facet | Andrés‐Benito, Pol Domínguez, Raúl Colomina, Maria J. Llorens, Franc Povedano, Mònica Ferrer, Isidre |
author_sort | Andrés‐Benito, Pol |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8580344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-85803442022-09-07 Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression Andrés‐Benito, Pol Domínguez, Raúl Colomina, Maria J. Llorens, Franc Povedano, Mònica Ferrer, Isidre Aging (Albany NY) Correction Impact Journals 2021-10-31 /pmc/articles/PMC8580344/ /pubmed/34738920 http://dx.doi.org/10.18632/aging.203667 Text en Copyright: © 2021 Andrés‐Benito et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Andrés‐Benito, Pol Domínguez, Raúl Colomina, Maria J. Llorens, Franc Povedano, Mònica Ferrer, Isidre Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
title | Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
title_full | Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
title_fullStr | Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
title_full_unstemmed | Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
title_short | Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
title_sort | correction for: ykl40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580344/ https://www.ncbi.nlm.nih.gov/pubmed/34738920 http://dx.doi.org/10.18632/aging.203667 |
work_keys_str_mv | AT andresbenitopol correctionforykl40insporadicamyotrophiclateralsclerosiscerebrospinalfluidlevelsasaprognosismarkerofdiseaseprogression AT dominguezraul correctionforykl40insporadicamyotrophiclateralsclerosiscerebrospinalfluidlevelsasaprognosismarkerofdiseaseprogression AT colominamariaj correctionforykl40insporadicamyotrophiclateralsclerosiscerebrospinalfluidlevelsasaprognosismarkerofdiseaseprogression AT llorensfranc correctionforykl40insporadicamyotrophiclateralsclerosiscerebrospinalfluidlevelsasaprognosismarkerofdiseaseprogression AT povedanomonica correctionforykl40insporadicamyotrophiclateralsclerosiscerebrospinalfluidlevelsasaprognosismarkerofdiseaseprogression AT ferrerisidre correctionforykl40insporadicamyotrophiclateralsclerosiscerebrospinalfluidlevelsasaprognosismarkerofdiseaseprogression |